46.30
1.47%
-0.69
Handel nachbörslich:
46.30
Inari Medical Inc Aktie (NARI) Neueste Nachrichten
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action ... - Business Wire
Business Wire
INVESTOR ALERT: Edelson Lechtzin LLP Urges Inari Medical, Inc. (NASDAQ: NARI) Shareholders With Substantial ... - GlobeNewswire
GlobeNewswire
Shareholders that lost money on Inari Medical, Inc.(NARI) Urged to Join Class Action – Contact The Gross Law Firm to ... - GlobeNewswire
GlobeNewswire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc ... - Business Wire
Business Wire
Inari Medical, Inc. (NASDAQ:NARI) Stock Position Lowered by Swiss National Bank - Defense World
Defense World
Inari Medical, Inc. (NASDAQ:NARI) CFO Mitch C. Hill Sells 6,000 Shares - MarketBeat
MarketBeat
Inari Medical CFO sells over $275k in company stock - Investing.com India
Investing.com India
Inari Medical CFO sells over $275k in company stock - Investing.com
Investing.com
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Inari Medical, Inc. - NARI - GlobeNewswire
GlobeNewswire
Stockholder Alert: Robbins LLP Informs Investors that a Class Action Against Inari Medical, Inc. (NARI) - GlobeNewswire
GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before ... - GlobeNewswire
GlobeNewswire
NARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inari Medical, Inc. Investors with ... - PR Newswire
PR Newswire
Inari Medical (NARI) Fell on Investor Concerns - Yahoo Canada Finance
Yahoo Canada Finance
NARI INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Inari Medical, Inc. Investors with ... - Business Wire
Business Wire
INARI MEDICAL SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds ... - Business Wire
Business Wire
Vein Tech Maker Faces Investor Suit Over DOJ Kickback Probe - Law360
Law360
Inari Medical, Inc. (NARI) Litigation Initiated After NARI Disclosed DOJ Probe of Business Practices – Hagens Berman - GlobeNewswire
GlobeNewswire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc. (NARI) Investors - Business Wire
Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inari Medical - PR Newswire
PR Newswire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before ... - PR Newswire
PR Newswire
INARI MEDICAL, INC. (NASDAQ: NARI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities ... - GlobeNewswire
GlobeNewswire
Russell Investments Group Ltd. Boosts Stake in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
MarketBeat
Russell Investments Group Ltd. Boosts Stock Position in Inari Medical, Inc. (NASDAQ:NARI) - Defense World
Defense World
Benjamin F. Edwards & Company Inc. Purchases 236 Shares of Inari Medical, Inc. (NASDAQ:NARI) - Defense World
Defense World
Inari Medical, Inc. (NASDAQ:NARI) Shares Sold by Essex Investment Management Co. LLC - MarketBeat
MarketBeat
Inari Medical (NARI) Stock Forecast and Price Target 2024 - MarketBeat
MarketBeat
Atria Wealth Solutions Inc. Takes $211000 Position in Inari Medical, Inc. (NASDAQ:NARI) - Defense World
Defense World
Is a Surprise Coming for Inari Medical (NARI) This Earnings Season? - Yahoo New Zealand News
Yahoo New Zealand News
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. - GlobeNewswire
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. - GlobeNewswire
GlobeNewswire
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
GlobeNewswire Inc.
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference - Yahoo Finance
Yahoo Finance
Inari Medical, Inc. (NASDAQ:NARI) Receives $65.71 Consensus Price Target from Analysts - Defense World
Defense World
Inari Medical, Inc. (NASDAQ:NARI) Just Reported, And Analysts Assigned A US$66.00 Price Target - Yahoo Finance UK
Yahoo Finance UK
Inari Medical, Inc. (NASDAQ:NARI) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Inari Medical First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Yahoo Finance
Earnings call: Inari Medical reports strong Q1 with revenue growth of 23% - Investing.com
Investing.com
Inari Medical (NARI) Q1 Earnings Miss Estimates, OpEx Rises
Zacks Investment Research
Piper Sandler lowers Inari Medical stock PT; awaits U.S. VTE franchise clarity - Investing.com
Investing.com
Inari Medical (NARI) Q1 Earnings Miss Estimates, OpEx Rises - Zacks Investment Research
Zacks Investment Research
Inari Medical, Inc. (NARI) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Inari Medical Reports First Quarter 2024 Financial Results - GlobeNewswire
GlobeNewswire
Inari Medical Reports First Quarter 2024 Financial Results
GlobeNewswire Inc.
Inari Medical Inc (NARI) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Rising Operating Losses - GuruFocus.com
GuruFocus.com
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
Zacks Investment Research
What's in Store for These 5 Medical Device Stocks in Q1 Earnings? - Yahoo Finance
Yahoo Finance
Inari Medical (NARI) Scheduled to Post Earnings on Tuesday - Defense World
Defense World
Investor News Announces Civil Investigative Demand Served to Inari Medical by U.S. Department of Justice – Contact ... - GlobeNewswire
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. - GlobeNewswire
GlobeNewswire
Inari Medical, Inc. (NARI) Downgraded by Analysts Due to Pending DOJ Probe – Hagens Berman - GlobeNewswire
GlobeNewswire
Kapitalisierung:
|
Volumen (24h):